Facilitated by deregulation and the growing liberalization of markets worldwide, companies are increasingly making cross-border rather than domestic M&A deals. This report, based on interviews with senior executives from companies that have undergone cross-border M&A transactions, discusses the role of corporate governance before, during, and after a cross-border merger.

Topics covered:

• corporate governance issues in formulating the M&A transaction
• corporate governance issues as the transaction progresses
• the role of shareholders in M&As

Features insights from representatives of:

AstraZeneca, Aventis, BP Amoco, Daimler Chrysler, DWS Investments, Georgeson Shareholder Communications, Goodyear, Hermes Pensions Management, MeritaNordbanken, Standard Life Investments, ThysssenKrupp, and TIAA-CREF